| Date | Time | Source | Announcement |
|---|---|---|---|
| 05 Jul 2011 | 01:30 PM | Issue of Equity | |
| 27 Jun 2011 | 07:00 AM | Data presented at heart valve meeting | |
| 22 Jun 2011 | 08:35 AM | Receives EUR280,000 Grant Funding | |
| 16 Jun 2011 | 07:00 AM | Promising data at leading US conference | |
| 13 Jun 2011 | 07:00 AM | Directorate Appointment | |
| 03 Jun 2011 | 10:02 AM | AGM Statement | |
| 11 May 2011 | 07:00 AM | Positive Results in Clinical Evaluation of dCELL | |
| 10 May 2011 | 01:15 PM | Tissue Regenix founder recieves UKRC award | |
| 04 May 2011 | 07:00 AM | Final Results | |
| 21 Apr 2011 | 07:00 AM | Tissue Regenix enters commercialisation agreement | |
| 29 Mar 2011 | 07:00 AM | Directorate Change | |
| 10 Mar 2011 | 07:00 AM | Notice of allowance of patent received | |
| 21 Feb 2011 | 07:00 AM | Business Development Manager Appointed | |
| 04 Jan 2011 | 11:27 AM | Holding(s) in Company | |
| 30 Dec 2010 | 09:05 AM | Holding(s) in Company | |
| 23 Dec 2010 | 12:44 PM | Change of Adviser | |
| 21 Dec 2010 | 10:12 AM | Adviser - Change of Name | |
| 16 Dec 2010 | 07:00 AM | Research Update | |
| 10 Dec 2010 | 09:20 AM | Change of Adviser | |
| 30 Nov 2010 | 03:48 PM | Total Voting Rights | |
| 26 Nov 2010 | 03:12 PM | Change of Registered Office | |
| 23 Nov 2010 | 05:18 PM | Issue of Equity | |
| 20 Oct 2010 | 07:00 AM | Half Yearly Report | |
| 18 Aug 2010 | 02:19 PM | Holding(s) in Company | |
| 10 Aug 2010 | 07:00 AM | CE Mark Grant | |
| 05 Aug 2010 | 03:43 PM | Patents approved | |
| 01 Jul 2010 | 10:38 AM | Holding(s) in Company | |
| 29 Jun 2010 | 04:37 PM | Issue of Equity | |
| 29 Jun 2010 | 07:00 AM | First Day of Dealings | |
| 20 Jun 2007 | 07:00 AM | Disposal & Administration | |
| 01 Jun 2007 | 07:00 AM | Board change | |
| 17 May 2007 | 03:58 PM | Review of strategic options | |
| 03 Apr 2007 | 02:28 PM | Rule 2.10 Announcement | |
| 30 Mar 2007 | 05:03 PM | Strategic Review | |
| 27 Mar 2007 | 05:20 PM | Holding(s) in Company | |
| 21 Mar 2007 | 03:18 PM | Directorate Change | |
| 21 Mar 2007 | 03:14 PM | Clarification re. SFO | |
| 06 Mar 2007 | 07:00 AM | Board Changes | |
| 26 Feb 2007 | 05:04 PM | Directorate Change | |
| 23 Feb 2007 | 01:00 PM | Holding(s) in Company | |
| 16 Feb 2007 | 08:21 AM | Holding(s) in Company | |
| 14 Feb 2007 | 07:00 AM | Board Appt and Bank Funding | |
| 08 Feb 2007 | 07:00 AM | Board Appointments | |
| 31 Jan 2007 | 05:21 PM | Management Actions | |
| 31 Jan 2007 | 03:51 PM | Holding(s) in Company | |
| 26 Jan 2007 | 07:30 AM | Trading Update | |
| 25 Jan 2007 | 07:00 AM | Holding(s) in Company | |
| 23 Jan 2007 | 05:40 PM | Holding(s) in Company | |
| 22 Jan 2007 | 07:00 AM | Holding(s) in Company | |
| 19 Jan 2007 | 04:39 PM | Total Voting Rights |
Tissue Regenix Group PLC is a medical technology company that develops regenerative products. Founded in 2006, it is listed in London under the ticker TRX.
TRX share price launched at 9,000p in 2006.